Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Sep;21(5):599-610.
doi: 10.1007/s10741-016-9552-9.

Diastolic dysfunction in cirrhosis

Affiliations
Review

Diastolic dysfunction in cirrhosis

Søren Møller et al. Heart Fail Rev. 2016 Sep.

Abstract

Development of esophageal varices, ascites, and hepatic nephropathy is among the major complications of cirrhosis. The presence of cirrhotic cardiomyopathy, which includes a left ventricular diastolic dysfunction (DD), seems to deteriorate the course of the disease and the prognosis. Increased stiffness of the cirrhotic heart may decrease the compliance and result in DD. The prevalence of DD in cirrhotic patients averages about 50 %. It can be evaluated by transmitral Doppler echocardiography, tissue Doppler echocardiography, and cardiac magnetic resonance imaging. There seems to be a relation between DD and the severity of liver dysfunction and the presence of ascites. After liver transplantation, DD worsens the prognosis and increases the risk of graft rejection, but DD improves after few months. Insertion of a transjugular intrahepatic portosystemic shunt increases left ventricular diastolic volumes, and DD is a predictor of poorer survival in these patients. Future studies should aim at disclosing pathophysiological mechanisms behind the developing of DD in cirrhosis in relation to patient characteristics, development of complications, treatment, and risk associated with interventional procedures.

Keywords: Cardiac dysfunction; Cirrhotic cardiomyopathy; Hyperdynamic syndrome; Systolic dysfunction; Vasodilatation.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Hepatol. 2010 Sep;53(3):397-417 - PubMed
    1. Liver Int. 2011 Apr;31(4):534-40 - PubMed
    1. Liver Int. 2013 Sep;33(8):1158-65 - PubMed
    1. J Clin Med Res. 2015 Mar;7(3):137-44 - PubMed
    1. Gut. 1999 May;44(5):743-8 - PubMed

Publication types

MeSH terms

LinkOut - more resources